Saving the Hearts of Women Through Prevention

Overview

Provider Statement

This continuing medical education activity is jointly provided by  and

Support Statement

This activity is supported by educational grants from Merck & Co., Inc. and Novartis Pharmaceuticals Corporation.

Target Audience

The intended audience for this activity is cardiologists, family medicine physicians, internists and other health care professionals involved in the management of patients with cardiovascular risk.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Describe gender-specific factors that have an impact on cardiovascular risk (CV) risk in women.
• Review clinical guidelines and modalities to screen women for CV risk.
• Evaluate the latest clinical data on obesity and the impact of weight loss on CV risk in women.
• Review recent clinical data of newer anti-diabetes medications and their impact on CV risk.
• Evaluate recent data regarding the impact of non-statin therapies on the reduction of low-density lipoprotein cholesterol (LDL-C) or triglycerides in patients with atherosclerotic cardiovascular disease (ASCVD) with or without risk enhancers.
• Evaluate recent data regarding the impact of non-statin therapies on the reduction of LDL-C or triglycerides in patients with ASCVD with or without risk enhancers.

Activity Co-Chairs

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC
President-Elect American Society for Preventive Cardiology

Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
Associate Professor of Medicine (Cardiology)
Associate Director of Preventive Cardiology
Division of Cardiology
Johns Hopkins University School of Medicine
Baltimore, MD

Faculty

Harold E. Bays, MD, FOMA, FTOS, FACC
Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY

Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Gerald S. Berenson Endowed Chair in Preventive Cardiology
Professor of Medicine
John W. Deming Department of Medicine
Tulane University School of Medicine
New Orleans, LA

Charles German MD, MS
Assistant Professor of Medicine
Section of Cardiology
University of Chicago
Chicago, IL

Ann Marie Navar, MD, PhD
Associate Professor of Medicine
Division of Cardiology
UT Southwestern Medical Center
Dallas, TX

Priyanka Satish, MD
Cardiology Fellow
Houston Methodist DeBakey Heart and Vascular Center
Houston, TX

Michael D. Shapiro, DO, MCR, FACC
Fred M. Parrish Professor of Cardiology and Molecular Medicine
Section on Cardiovascular Medicine
Wake Forest School of Medicine
Director, Center for Preventive Cardiology
Wake Forest Baptist Health
Winston-Salem, NC

Pam R. Taub, MD, FACC, FASPC
Professor of Medicine
Director of Step Family Cardiac Rehabilitation and Wellness Center
Division of Cardiovascular Medicine
University of California San Diego
La Jolla, CA

Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Vindico Medical Education and the American Society For Preventive Cardiology. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 2.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, September 30, 2022, to September 29, 2023.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the learning objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 5 out of 7 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Activity Co-Chairs and Faculty report the following relationship(s)

Harold E. Bays, MD, FOMA, FTOS, FACC
Consultant: Altimmune, Amgen, Boehringer Ingelheim
Speaker Contracted by Ineligible Company: Novo Nordisk
Independent Research Contractor (Paid to Institution): Alcon, Altimmune, Amgen, Boehringer Ingelheim, Lilly, Medtech/Epitomee, Novo Nordisk, Pfizer, Vivus

Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Consultant: Boehringer Ingelheim, Janssen, Lilly, Medtronic, Novartis, Quantum Genomics

Charles German MD, MS
No relevant financial relationships to disclose.

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC
No relevant financial relationships to disclose.

Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
Advisor: AstraZeneca, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, Pfizer

Ann Marie Navar, MD, PhD
Consultant: AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Lilly, New Amsterdam, Novartis, Novo Nordisk, Pfizer
Independent Research Contractor: Cerner
Independent Research Contractor (paid to institution): Amgen, Bristol Myers Squibb, Esperion, Janssen

Priyanka Satish, MD
No relevant financial relationships to disclose.

Michael D. Shapiro, DO, MCR, FACC
Advisor: Amgen, Esperion, Novartis, Novo Nordisk
Consultant: Ionis, Regeneron
Independent Research Contractor: Amgen, Novartis, Regeneron

Pam R. Taub, MD, FACC, FASPC
Consultant: Amgen, Bayer, Boehringer Ingelheim, Edwards, Esperion, Medtronic, Novartis, Novo Nordisk, Sanofi
Independent Research Contractor: Novartis
Individual Stocks and Stock Options: Epirium Bio

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education and American Society For Preventive Cardiology staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education and the American Society For Preventive Cardiology continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education or the American Society For Preventive Cardiology. Neither Vindico Medical Education, the American Society For Preventive Cardiology, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com